Results 141 to 150 of about 77,587 (217)

Calla, Torcuato, calla

, 1978
openaire   +1 more source

Codon usage patterns and genomic variation analysis of chloroplast genomes provides new insights into the evolution of Aroideae. [PDF]

Sci Rep
Jia X, Wei J, Chen Y, Zeng C, Deng C, Zeng P, Tang Y, Zhou Q, Huang Y, Zhu Q.   +9 more
europepmc   +1 more source

Bioethics: Whence Do We Derive the Norms? [PDF]

, 1979
O\u27Reilly, Sean
core   +1 more source

Correction: Advancing genetic improvement in the omics era: status and priorities for United States aquaculture. [PDF]

BMC Genomics
Andersen LK, Thompson NF, Abernathy JW, Ahmed RO, Ali A, Al-Tobasei R, Beck BH, Calla B, Delomas TA, Dunham RA, Elsik CG, Fuller SA, García JC, Gavery MR, Hollenbeck CM, Johnson KM, Kunselman E, Legacki EL, Liu S, Liu Z, Martin B, Matt JL, May SA, Older CE, Overturf K, Palti Y, Peatman EJ, Peterson BC, Phelps MP, Plough LV, Polinski MP, Proestou DA, Purcell CM, Quiniou SMA, Raymo G, Rexroad CE, Riley KL, Roberts SB, Roy LA, Salem M, Simpson K, Waldbieser GC, Wang H, Waters CD, Reading BJ, Aquaculture Genomics, Genetics and Breeding Workshop.   +46 more
europepmc   +1 more source

Creation, Procreation and Gift of Life [PDF]

, 1975
Sherlock, Richard
core   +1 more source

Evaluating the Predictive Value of HOMA-IR in Gestational Diabetes: A Case-Control Study from Romania. [PDF]

Diagnostics (Basel)
Iman AEH, Onel C, Furau G, Furau C, Furau R, Lucan M, Sandor M, Sachelarie L, Huniadi A.   +8 more
europepmc   +1 more source

Efficacy and safety of adding immune checkpoint inhibitors to standard chemotherapy or chemoradiotherapy for advanced or recurrent cervical cancer: a meta-analysis. [PDF]

Front Immunol
Zhou L, Sun C, Diao P, Wang J.
europepmc   +1 more source

Efficacy and safety of immune checkpoint inhibitors with chemoradiotherapy/chemotherapy in locally advanced cervical cancer patients: a systematic review and single-arm meta-analysis. [PDF]

J Gynecol Oncol
Piya IJ, Riya IJ, Sharma V.
europepmc   +1 more source

An <i>in silico</i> evaluation of lorlatinib as a potential therapy for novel amino acid substitutions in the tyrosine kinase domain of the ALK protein associated with cancer. [PDF]

Front Pharmacol
Zapata Dongo RJ, Poterico JA, Fontana D, Mologni L, Alvarez-Chacon C, Rojas-Armas J, Calla J.   +6 more
europepmc   +1 more source

Comment on "Predictive Value of Advanced Lung Cancer Inflammation Index and Development of a Nomogram for Prognosis in Patients with Cervical Cancer Treated with Radiotherapy" [Response to Letter]. [PDF]

J Inflamm Res
Yu Q, Jin X.
europepmc   +1 more source